250 related articles for article (PubMed ID: 35790913)
21. Generation of endoplasmic reticulum stress and inhibition of autophagy by plitidepsin induces proteotoxic apoptosis in cancer cells.
Losada A; Berlanga JJ; Molina-Guijarro JM; Jiménez-Ruiz A; Gago F; Avilés P; de Haro C; Martínez-Leal JF
Biochem Pharmacol; 2020 Feb; 172():113744. PubMed ID: 31812675
[TBL] [Abstract][Full Text] [Related]
22. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability.
Ding WX; Ni HM; Gao W; Yoshimori T; Stolz DB; Ron D; Yin XM
Am J Pathol; 2007 Aug; 171(2):513-24. PubMed ID: 17620365
[TBL] [Abstract][Full Text] [Related]
23. Clarithromycin overcomes stromal cell-mediated drug resistance against proteasome inhibitors in myeloma cells via autophagy flux blockage leading to high NOXA expression.
Moriya S; Kazama H; Hino H; Takano N; Hiramoto M; Aizawa S; Miyazawa K
PLoS One; 2023; 18(12):e0295273. PubMed ID: 38039297
[TBL] [Abstract][Full Text] [Related]
24. Proteasome inhibitors for multiple myeloma.
Okazuka K; Ishida T
Jpn J Clin Oncol; 2018 Sep; 48(9):785-793. PubMed ID: 30102324
[TBL] [Abstract][Full Text] [Related]
25. Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.
Auner HW; Moody AM; Ward TH; Kraus M; Milan E; May P; Chaidos A; Driessen C; Cenci S; Dazzi F; Rahemtulla A; Apperley JF; Karadimitris A; Dillon N
PLoS One; 2013; 8(9):e74415. PubMed ID: 24069311
[TBL] [Abstract][Full Text] [Related]
26. Cytotoxic synergy between the multikinase inhibitor sorafenib and the proteasome inhibitor bortezomib in vitro: induction of apoptosis through Akt and c-Jun NH2-terminal kinase pathways.
Yu C; Friday BB; Lai JP; Yang L; Sarkaria J; Kay NE; Carter CA; Roberts LR; Kaufmann SH; Adjei AA
Mol Cancer Ther; 2006 Sep; 5(9):2378-87. PubMed ID: 16985072
[TBL] [Abstract][Full Text] [Related]
27. The proteasome and proteasome inhibitors in multiple myeloma.
Gandolfi S; Laubach JP; Hideshima T; Chauhan D; Anderson KC; Richardson PG
Cancer Metastasis Rev; 2017 Dec; 36(4):561-584. PubMed ID: 29196868
[TBL] [Abstract][Full Text] [Related]
28. Indirubin-3'-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma.
Yu Z; Wei X; Liu L; Sun H; Fang T; Wang L; Li Y; Sui W; Wang K; He Y; Zhao Y; Huang W; An G; Meng F; Huang C; Yu T; Anderson KC; Cheng T; Qiu L; Hao M
EBioMedicine; 2022 Apr; 78():103950. PubMed ID: 35344764
[TBL] [Abstract][Full Text] [Related]
29. The novel, proteasome-independent NF-kappaB inhibitor V1810 induces apoptosis and cell cycle arrest in multiple myeloma and overcomes NF-kappaB-mediated drug resistance.
Meinel FG; Mandl-Weber S; Baumann P; Leban J; Schmidmaier R
Mol Cancer Ther; 2010 Feb; 9(2):300-10. PubMed ID: 20124446
[TBL] [Abstract][Full Text] [Related]
30. Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.
Tang ZH; Zhang LL; Li T; Lu JH; Ma DL; Leung CH; Chen XP; Jiang HL; Wang YT; Lu JJ
Oncotarget; 2015 Dec; 6(41):43911-26. PubMed ID: 26549806
[TBL] [Abstract][Full Text] [Related]
31. CRIP1 involves the pathogenesis of multiple myeloma via dual-regulation of proteasome and autophagy.
Tang P; Yu Z; Sun H; Liu L; Gong L; Fang T; Sun X; Xie S; An G; Xu Z; Qiu L; Hao M
EBioMedicine; 2024 Feb; 100():104961. PubMed ID: 38199044
[TBL] [Abstract][Full Text] [Related]
32. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma.
Hideshima T; Bradner JE; Wong J; Chauhan D; Richardson P; Schreiber SL; Anderson KC
Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8567-72. PubMed ID: 15937109
[TBL] [Abstract][Full Text] [Related]
33. Blocking autophagy overcomes resistance to dual histone deacetylase and proteasome inhibition in gynecologic cancer.
Bi J; Zhang Y; Malmrose PK; Losh HA; Newtson AM; Devor EJ; Thiel KW; Leslie KK
Cell Death Dis; 2022 Jan; 13(1):59. PubMed ID: 35039480
[TBL] [Abstract][Full Text] [Related]
34. Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.
Rizq O; Mimura N; Oshima M; Saraya A; Koide S; Kato Y; Aoyama K; Nakajima-Takagi Y; Wang C; Chiba T; Ma A; Jin J; Iseki T; Nakaseko C; Iwama A
Clin Cancer Res; 2017 Aug; 23(16):4817-4830. PubMed ID: 28490465
[No Abstract] [Full Text] [Related]
35. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.
Hui B; Shi YH; Ding ZB; Zhou J; Gu CY; Peng YF; Yang H; Liu WR; Shi GM; Fan J
Cancer; 2012 Nov; 118(22):5560-71. PubMed ID: 22517429
[TBL] [Abstract][Full Text] [Related]
36. The novel β2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells.
Kraus J; Kraus M; Liu N; Besse L; Bader J; Geurink PP; de Bruin G; Kisselev AF; Overkleeft H; Driessen C
Cancer Chemother Pharmacol; 2015 Aug; 76(2):383-96. PubMed ID: 26099967
[TBL] [Abstract][Full Text] [Related]
37. Research progress in proteasome inhibitor resistance to multiple myeloma.
Wu J; Liu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 46(8):900-908. PubMed ID: 34565737
[TBL] [Abstract][Full Text] [Related]
38. Acridine Derivatives as Inhibitors of the IRE1α-XBP1 Pathway Are Cytotoxic to Human Multiple Myeloma.
Jiang D; Tam AB; Alagappan M; Hay MP; Gupta A; Kozak MM; Solow-Cordero DE; Lum PY; Denko NC; Giaccia AJ; Le QT; Niwa M; Koong AC
Mol Cancer Ther; 2016 Sep; 15(9):2055-65. PubMed ID: 27307600
[TBL] [Abstract][Full Text] [Related]
39. The endoplasmic reticulum stress sensor IRE1α protects cells from apoptosis induced by the coronavirus infectious bronchitis virus.
Fung TS; Liao Y; Liu DX
J Virol; 2014 Nov; 88(21):12752-64. PubMed ID: 25142592
[TBL] [Abstract][Full Text] [Related]
40. Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemia.
Wilhelm T; Bick F; Peters K; Mohta V; Tirosh B; Patterson JB; Kharabi-Masouleh B; Huber M
Oncotarget; 2018 Jan; 9(3):2984-3000. PubMed ID: 29423023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
